Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Nematode latrophilin-like G-protein-coupled receptor, specifically Latrophilin-1 (LAT-1), is an adhesion-class G protein-coupled receptor (aGPCR) essential for the physiological function of nematodes (UniProt: P90768). It is widely expressed in the pharyngeal and body wall muscles, as well as the nervous system, where it regulates vital processes such as pharyngeal pumping, locomotion, and egg-laying (Willson et al., 2004). LAT-1 is recognized as the primary molecular target for the anthelmintic drug emodepside, a semi-synthetic cyclooctadepsipeptide used to treat parasitic worm infections (Harder et al., 2005). When emodepside binds to LAT-1, it acts as an agonist, initiating a signal transduction pathway involving Gq proteins and phospholipase C (Guest et al., 2007). This signaling cascade leads to the activation of SLO-1 calcium-activated potassium channels, resulting in the hyperpolarization of muscle cells and neurons. The consequence of this activation is flaccid paralysis of the nematode, which prevents feeding and movement, ultimately leading to the parasite's death. Beyond its role in drug interaction, LAT-1 is involved in developmental processes, including tissue polarity and cell alignment during embryogenesis. Due to its distinct pharmacological profile and essentiality in parasites, LAT-1 remains a focal point for developing novel treatments against resistant helminth strains.
Agonist; binding of emodepside to LAT-1 activates a Gq-protein signaling cascade (Gq/11 and Phospholipase C) that leads to the release of inhibitory neuropeptides or the direct activation of SLO-1 potassium channels, resulting in hyperpolarization and flaccid paralysis of the nematode (Willson et al., 2004; Guest et al., 2007).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Latrophilin-1 (Nematode) (LAT-1).